Table 1 Characteristics between the VTE group and the non-VTE group
Group | n | Gender (M/F) | Age (\(\stackrel{-}{x}\)±s) | ECOG PS (< 2/≥2) | History of VTE (Yes/No) | NSCLC/SCLC | Clinical stage (III-IV/I-II) | Hypertension (Yes/No) | Atrial fibrillation (Yes/No) | BMI (≥ 25/<25) |
|---|---|---|---|---|---|---|---|---|---|---|
VTE | 27 | 14/13 (51.9%) | 71.41 ± 8.16 | 5/22 (18.5%) | 10/17 (37.0%) | 22/5 (81.5%) | 25/2 (92.6%) | 17/10 (63.0%) | 5/22 (18.5%) | 8/19 (29.6%) |
Non-VTE | 131 | 102/29 (77.9%) | 64.36 ± 9.90 | 96/35 (73.3%) | 6/125 (4.6%) | 112/19 (85.5%) | 89/42 (67.9%) | 48/83 (36.6%) | 3/128 (2.3%) | 15/116 (11.5%) |
χ²/t | 0.701 | 3.722 | 29.113 | 25.912 | 0.280 | 6.772 | 6.405 | 12.265 | 5.948 | |
P-value | 0.403 | 0.054 | < 0.001* | < 0.001* | 0.597 | 0.009* | 0.011* | < 0.001* | 0.015* |